Elite Pharmaceuticals Inc
ELTP· OTC
Released Aug 14, 2024, after the close
10-Q filed Aug 14, 2024, 45 days after period end · 0001493152-24-032154
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $18.80M | $8.98M | $7.67M | $7.06M |
| Net Income | $615.77K | $1.14M | $305.88K | $2.39M |
| EPS Diluted |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.